Journal article
Platelet-activating anti-PF4 disorders: An overview
Abstract
Platelet factor 4 (PF4) is a highly cationic tetrameric protein that can be targeted by platelet-activating anti-PF4 antibodies of immunoglobulin G (IgG) class. Certain features of PF4, including its multivalent nature (duplicate antigen sites per tetramer), the ability of many PF4 tetramers to undergo close approximation through charge neutralization, and the dimeric binding of IgG molecules, results in formation of IgG-containing immune …
Authors
Warkentin TE
Journal
Seminars in Hematology, Vol. 59, No. 2, pp. 59–71
Publisher
Elsevier
Publication Date
April 2022
DOI
10.1053/j.seminhematol.2022.02.005
ISSN
0037-1963